Nitaara Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth -857.45%
- Ebitda -713.65%
- Net Worth -112.58%
- Total Assets 1149.87%
About Nitaara Lifesciences
Nitaara Lifesciences Private Limited (NLPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 February 2018 (Six years and 11 months 0 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mohit Jain and Harkesh Jain serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U51909DL2018PTC330161
- Company No.
330161
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Feb 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Nitaara Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohit Jain  | Director | 28-Feb-2018 | Current |
| Harkesh Jain | Director | 28-Feb-2018 | Current |
Financial Performance of Nitaara Lifesciences.
Nitaara Lifesciences Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 857.45% decrease in profit. The company's net worth observed a substantial decline by a decrease of 112.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nitaara Lifesciences?
In 2021, Nitaara Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mhj Pharmaconcepts Private LimitedMohit Jain and Harkesh Jain are mutual person
Ratna Holidays LlpMohit Jain is a mutual person
- Dlr Factor Llp
Mohit Jain is a mutual person
- Pellagic Resorts Private Limited
Mohit Jain is a mutual person
- Pellagic Gourmet Concepts Private Limited
Mohit Jain is a mutual person
- Nitaara Foundation
Mohit Jain and Harkesh Jain are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nitaara Lifesciences?
Unlock and access historical data on people associated with Nitaara Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nitaara Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nitaara Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
